循证医学在中国的发展:回顾与展望  

Development of evidence-based medicine in China:retrospect and prospect

作　　者：李幼平[1] 李静[1] 孙鑫[1] 刘鸣[2] 张鸣明[1] 杜亮[1,3] 邝心颖[1] 喻佳洁[1] 卫茂玲[1] 

机构地区：[1]四川大学华西医院中国循证医学中心,四川成都610041 [2]四川大学华西医院神经内科,四川成都610041 [3]四川大学华西医院中国循证医学杂志编辑部,四川成都610041

出　　处：《兰州大学学报（医学版）》2016年第1期25-28,共4页Journal of Lanzhou University（Medical Sciences）

摘　　要：循证医学被誉为21世纪的临床医学,引入中国20年来,以其先进的理念、科学的方法和高质量的证据深刻地影响着中国的卫生决策和医疗实践。本文回顾了循证医学产生的背景和发展,以及引入中国后在学科、平台建设、人才培养等方面的发展历程和取得的成就,特别是对其中的关键人物和历史事件进行了介绍,并对循证医学在中国未来的发展进行了展望。Evidence based-medicine is known as clinical medicine in the 21 st century.It was introduced into China for 20 years and has had a major impact on healthcare policy and medical practice with its advanced concepts,scientific method and high quality evidence.The paper reviewed the background and development of emergence of evidence based medicine,as well as its development process and achievements in the discipline,platform,personnel training and other aspects after its introduction into China,especially introduce the associated key figures and historical events,and prospect future development of the evidence-based medicine in China.

关 键 词：循证医学 COCHRANE协作网 系统评价 

分 类 号：R-03[医药卫生]